new glp-1 drug retatrutide Treatment with retatrutide, an agonist to GLP-1, GIP, and glucagon Eli Lilly's Weight Loss Superdrug

Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial

Our program is overseen by Dr

The 2021 Hawaii Pregnancy Risk Assessment Monitoring Surveys revealed that NH women are less likely to initiate breastfeeding and to be breastfeeding at 8 weeks

Common mild side effects across GLP-1 medications include: Nausea, particularly during early weeks and dose increases Vomiting Diarrhea or constipation Injection site reactions Decreased appetite These effects are most pronounced early in treatment and typically lessen as the body adjusts

JL20268) and TNF- (cat